Mice, microbes and models of infection

Nature Reviews Genetics

Volumn 4, Issue 3, 2003, Pages 195-205

  Buer, Jan ^a,b   Balling, Rudi ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL GENE; EXPERIMENTAL MOUSE; GENE EXPRESSION; GENETICS; IMMUNITY; IN VIVO STUDY; INBRED STRAIN; INFECTION; INFECTION SENSITIVITY; MICROORGANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BACTERIAL INFECTIONS; CATION TRANSPORT PROTEINS; COMMUNICABLE DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; DROSOPHILA PROTEINS; GENES, BACTERIAL; GENETIC SCREENING; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUTATION; NERVE TISSUE PROTEINS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTORS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0037374524     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1019     Document Type: Review

References (111)

1. Flajnik, M. F. Comparative analyses of immunoglobulin genes: surprises and portents. Nature Rev. Immunol. 2, 688-698 (2002).
2. Grüneberg, H. in The Genetics of the Mouse 421-434 (Martinus Nijhoff, The Hague, 1952).
3. Shultz, L. D. Immunological mutants of the mouse. Am. J. Anat. 191, 303-311 (1991).
4. Plant, J. & Glynn, A. A. Locating salmonella resistance gene on mouse chromosome 1. Clin. Exp. Immunol. 37, 1-6 (1979).
5. Plant, J. E., Blackwell, J. M., O'Brien, A. D., Bradley, D. J. & Glynn, A. A. Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature 297, 510-511 (1982).
6. Bradley, D. J., Taylor, B. A., Blackwell, J., Evans, E. P. & Freeman, J. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin. Exp. Immunol. 37, 7-14 (1979).
7. Skamene, E. et al. Genetic regulation of resistance to intracellular pathogens. Nature 297, 506-509 (1982).
8. Gros, P., Skamene, E. & Forget, A. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG). J. Immunol. 131, 1966-1972 (1983).
9. Schurr, E., Skamene, E., Forget, A. & Gros, P. Linkage analysis of the Bcg gene on mouse chromosome 1. Identification of a tightly linked marker. J. Immunol. 142, 4507-4513 (1989).
10. Malo, D., Vidal, S. M., Hu, J., Skamene, E. & Gros, P. High-resolution linkage map in the vicinity of the host resistance locus Bcg. Genomics 16, 655-663 (1993).
11. Malo, D., Vidal, S., Lieman, J. H., Ward, D. C. & Gros, P. Physical delineation of the minimal chromosomal segment encompassing the murine host resistance locus Bcg. Genomics 17, 667-675 (1993).
12. Vidal, S. M., Malo, D., Vogan, K., Skamene, E. & Gros, P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73, 469-485 (1993). References 9-12 discuss the cloning of the first host-resistance gene Nramp1.
13. Blackwell, J. M. et al. SLCL1A1 (formerly NRAMP1) and disease resistance. Cell Microbiol. 3, 773-784 (2001).
14. Vidal, S. et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655-666 (1995).
15. Govoni, G. et al. The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele. Infect. Immun. 64, 2923-2929 (1996).
16. Casanova, J. L. & Abel, L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20, 581-620 (2002).
17. North, R. J., LaCourse, R., Ryan, L. & Gros, P. Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice. Infect. Immun. 67, 5811-5814 (1999).
18. Kramnik, I., Dietrich, W. F., Demant, P. & Bloom, B. R. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 97, 8560-8565 (2000).
19. Molmeret, M. & Abu, K. Y. How does Legionella pneumophila exit the host cell? Trends Microbiol. 10, 258-260 (2002).
20. Gao, L. Y. & Abu, K. Y. Apoptosis in macrophages and alveolar epithelial cells during early stages of infection by Legionella pneumophila and its role in cytopathogenicity. Infect. Immun. 67, 862-870 (1999).
21. Gao, L. Y. & Abu, K. Y. Activation of caspase 3 during Legionella pneumophila-induced apoptosis. Infect. Immun. 67, 4886-4894 (1999).
22. Yoshida, S., Goto, Y., Mizuguchi, Y., Nomoto, K. & Skamene, E. Genetic control of natural resistance in mouse macrophages regulating intracellular Legionella pneumophila multiplication in vitro. Infect. Immun. 59, 428-432 (1991).
23. Yamamoto, Y., Klein, T. W. & Friedman, H. Legionella pneumophila growth in macrophages from susceptible mice is genetically controlled. Proc. Soc. Exp. Biol. Med. 196, 405-409 (1991).
24. Yamamoto, Y., Klein, T. W., Brown, K. & Friedman, H. Differential morphologic and metabolic alterations in permissive versus nonpermissive murine macrophages infected with Legionella pneumophila. Infect. Immun. 60, 3231-8237 (1992).
25. Yamamoto, Y., Klein, T. W., Newton, C. A., Widen, R. & Friedman, H. Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect. Immun. 56, 370-375 (1988).
26. Diez, E., et al. Genetic and physical mapping of the mouse host resistance locus Lgn1. Mamm. Genome 8, 682-685 (1997).
27. Growney, J. D. & Dietrich, W. F. High-resolution genetic and physical map of the Lgn1 interval in C57BL/6J implicates Naip2 or Naip5 in Legionella pneumophila pathogenesis. Genome Res. 10, 1158-1171 (2000).
28. Diez, E. et al. Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nature Genet. 33, 55-60 (2003).
29. Wright, E. K. et al. Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila. Curr. Biol. 13, 27-36 (2003). References 28 and 29 provide clear evidence that Naip5 (Birc1e) is the gene associated with resistance to Legionella pneumophila in mice.
30. Medzhilov, R. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1, 135-145 (2001). An excellent review that summarizes present concepts of Toll like receptors and innate immunity.
31. Hashimoto, C., Hudson, K. L. & Anderson, K. V. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52, 269-279 (1988).
32. Lemaitre, B., Nicolas, E., Michnaut, L., Reichart, J. M. & Hoffman, J. A. The dorsoventral regulatory cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983 (1996). A landmark paper and a crucial demonstration of the immune function of Toll and of the regulatory gene cassette that establishes dorsoventral polarity in Drosophila.
33. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997). This paper describes the first characterized mammalian Toll - human Tlr4.
34. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
35. Qureshi, S. T. et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189, 615-625 (1999). References 34 and 35 describe the first indication of TLR4 function in vivo.
36. Heppner, G. & Weiss, D. A. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J. Bacteriol. 90, 696-703 (1965).
37. Sultzer, B. M. Genetic control of leucocyte responses to endotoxin. Nature 219, 1253-1254 (1968).
38. Watson, J. & Riblet, R. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic response to lipopolysaccharides. J. Exp. Med. 140, 1147-1161 (1974).
39. Malo, D. et al. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23, 51-61 (1994).
40. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. & Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433 (1990).
41. Haziot, A. et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4, 407-414 (1996).
42. Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782 (1999).
43. Schromm, A. B. et al. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194, 79-88 (2001).
44. Lien, E. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest 105, 497-504 (2000).
45. Poltorak, A., Ricciardi-Castagnoli, P., Citterio, S. & Beutler, B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc. Natl Acad. Sci. USA 97, 2163-2167 (2000).
46. da Silva, C. J., Soldau, K., Christen, U., Tobias, P. S. & Ulevitch, R. J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex, transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276, 21129-21135 (2001).
47. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNF α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411 (1996).
48. Flynn, J. L. et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561-572 (1995).
49. Netea, M. G. et al. Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways. Eur. J. Immunol. 31, 2529-2538 (2001).
50. Kamradt, A. E., Greiner, M., Ghiara, P. & Kaufmann, S. H. Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants. Microbes Infect. 2, 593-597 (2000).
51. Yamada, H., Mizumo, S., Horai, R., Iwakura, Y. & Sugawara, I. Protective role of interleukin-1 in mycobacterial infection in IL-1 α/β double-knockout mice. Lab. Invest. 80, 759-767 (2000).
52. Hultgren, O. H., Svensson, L. & Tarkowski, A. Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J. Immunol. 168, 5207-5212 (2002).
53. Shinozawa, Y. et al. Role of interferon-γ in inflammatory responses in murine respiratory infection with Legionella pneumophila. J. Med. Microbiol. 51, 225-230 (2002).
54. Reznikov, L. L. et al. Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1β. Biol. Reprod. 80, 1231-1238 (1999).
55. Zheng, H. et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 β-deficient mice. Immunity 3, 9-19 (1995).
56. Dai, W. J., Kohler, G. & Brombacher, F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158, 2259-2267 (1997).
57. Brombacher, F. et al. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 11, 325-332 (1999).
58. Kopf, M et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342 (1994).
59. Ladel, C. H. et al. Lethal tuberculosis in interleukin-6- deficient mutant mice. Infect. Immun. 65, 4643-4649 (1997).
60. van Der, P. T. et al. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 176, 439-444 (1997).
61. Sugawara, I., Yamada, H., Mizuno, S. & Iwakura, Y. IL-4 is required for defense against mycobacterial infection. Microbiol. Immunol. 44, 971-979 (2000).
62. McKenzie, G. J. et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9, 423-432 (1998).
63. Matthews, D. J. et al. IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 164, 1458-1462 (2000).
64. + TCR-α-β cells and IFN-γ in bacterial clearance independent of intracellular location. J. Immunol. 156, 3321-3328 (1998).
65. Harty, J. T. & Bevan, M. J. Specific immunity to Listeria monocytogenes in the absence of IFN-γ. Immunity 3, 109-117 (1995).
66. Flynn, J. L. et al. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254 (1993).
67. Wille, U., Villegas, E. N., Striepen, B., Roos, D. S. & Hunter, C. A. Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii. Parasite Immunol. 23, 291-296 (2001).
68. Cooper, A.M. et al. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168, 1322-1327 (2002).
69. Kinjo, Y. et al. Contribution of lL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J. Immunol. 169, 323-329 (2002).
70. Wei, X. Q. et al. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163, 2821-2828 (1999).
71. Jacobs, M., Brown, N., Allie, N., Gulert, R. & Ryffel, B. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 100, 494-501 (2000).
72. Shanahan, F. Immunology: therapeutic manipulation of gut flora. Science 289, 1311-1312 (2000).
73. Steidler, L. et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352-1355 (2000). A paper that provides a new concept for mucosal immune modulation in mice by in situ delivery of cytokines using genetically engineered Lactococcus lactis.
74. Strober, W., Fuss, I. J. & Blumberg, R. S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20, 495-549 (2002). A review that provides a broad overview of mucosal models of inflammation mainly in mice.
75. Lengeling, A., Pfeffer, K. & Balling, R. The battle of two genomes: genetics of bacterial host/pathogen interactions in mice. Mamm. Genome 12, 261-271 (2001).
76. Jouanguy, E. et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335, 1956-1961 (1996).
77. Newport, M. J. et al. A mutation in the interferon-γ- receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941-1949 (1996).
78. Tracey, K. J. & Abraham, E. From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies? Shock 11, 224-225 (1999).
79. -/- mice is T cell and IL-12 dependent.
80. Pfeffer, K. et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L, monocytogenes infection. Cell 73, 457-467 (1993).
81. Rothe, J. et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802 (1993). References 80 and 81 are landmark papers showing the impact of knockout mice for the study of infectious disease.
82. Chan, F. K. et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354 (2000).
83. Erickson, S. L. et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560-563 (1994).
84. Flynn, J. L. & Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (2001).
85. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993). A publication that provides key evidence that IL-10 is important for maintaining immune homeostasis.
86. Moore, K. W., de Waal, M. R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
87. Trinchieri, G. Regulatory role of T cells producing both interferon γ and interleukin 10 in persistent infection. J. Exp. Med. 194, F53-F57 (2001). Important study analysing the role of regulatory T cells in persistent infection.
88. Un, M. T., Hinton, D. R., Parra, B., Stohlman, S. A. & van der Veen, R. C. The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 245, 270-280 (1998).
89. Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
90. Buer, J. et al. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II- restricted T cells anergized in vivo. J. Exp. Med. 187, 177-183 (1998).
91. Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nature Rev. Immunol. 2, 46-53 (2002).
92. Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200 (2001).
93. Mahan, M. J., Heithoff, D. M., Sinsheimer, R. L. & Low, D. A. Assessment of bacterial pathogenesis by analysis of gene expression in the host. Annu. Rev. Genet. 34, 139-164 (2000).
94. Kato-Maeda, M., Gao, Q. & Small, P. M. Microarray analysis of pathogens and their interaction with hosts. Cell Microbiol. 3, 713-719 (2001).
95. Mahan, M. J., Slauch, J. M. & Mekalanos, J. J. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259, 686-688 (1993). This paper introduces IVET technology.
96. VanBogelen, R. A., Greis, K. D., Blumenthal, R. M., Tani, T. H. & Matthews, R. G. Mapping regulatory networks in microbial cells. Trends Microbiol. 7, 320-328 (1999).
97. Chiang, S. L., Mekalanos, J. J. & Holden, D. W. In vivo genetic analysis of bacterial virulence. Annu. Rev. Microbiol. 53, 129-154 (1999).
98. Handfield, M. & Levesque, R. C. Strategies for isolation of in vivo expressed genes from bacteria. FEMS Microbiol. Rev. 23, 69-91 (1999).
99. Camilli, A. & Mekalanos, J. J. Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol. Microbiol. 18, 671-683 (1995).
100. Camilli, A., Beattie, D. T. & Mekalanos, J. J. Use of genetic recombination as a reporter of gene expression. Proc. Natl Acad. Sci. USA 91, 2634-2638 (1994).
101. Valdivia, R. H. & Falkow, S. Fluorescence-based isolation of bacterial genes expressed within host cells. Science 277, 2007-2011 (1997).
102. Valdivia, R. H., Hromockyj, A. E., Monack, D., Ramakrishnan, L. & Falkow, S. Applications for green fluorescent protein (GFP) in the study of host-pathogen interactions. Gene 173, 47-52 (1996).
103. Barker, L. P., Brooks, D. M. & Small, P. L. The identification of Mycobacterium marinum genes differentially expressed in macrophage phagosomes using promoter fusions to green fluorescent protein. Mol. Microbiol. 29, 1167-1177 (1998).
104. Chiang, S. L. & Mekalanos, J. J. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol. Microbiol. 27, 797-805 (1998).
105. Coulter, S. N. et al. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. Microbiol. 30, 393-404 (1998).
106. Mei, J. M., Nourbakhsh, F., Ford, C. W. & Holden, D. W. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol. Microbiol. 26, 399-407 (1997).
107. Schwan, W. R. et al. Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models. Infect. Immun. 66, 567-572 (1998).
108. Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562 (2002).
109. Hall, N. et al. Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature 419, 527-531 (2002).
110. Carlton, J. M. et al. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 419, 512-519 (2002).
111. Wilson, M., McNab, R. & Henderson, B. Bacterial Disease Mechanisms: an Introduction to Cellular Microbiology (Cambridge Univ. Press, UK, 2002).